CMBI: DualityBio-B (09606) Elfe-D Combination Data Reinforces ADC + IO 2.0 Thesis, Rating "Buy"

Zhitong Finance APP has learned that CMBI has issued a research report stating that it believes the valuation of DualityBio-B (09606) is still primarily driven by the B7-H3 ADC asset Elfe-D, and the firm maintains a "Buy" rating with a target price of HK$284.5.